Tulane University School of Medicine
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1834-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- https://medicine.tulane.edu
Clinical Trials
20
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials
Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma
- Conditions
- Relapsed Multiple MyelomaRefractory Multiple Myeloma
- Interventions
- First Posted Date
- 2021-12-28
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- Tulane University School of Medicine
- Registration Number
- NCT05170789
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence
- Conditions
- Atrial Fibrillation RecurrentAtrial Fibrillation
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Tulane University School of Medicine
- Target Recruit Count
- 22
- Registration Number
- NCT04704050
- Locations
- 🇺🇸
University of Colorado Health Memorial, Colorado Springs, Colorado, United States
🇺🇸Emory University, Atlanta, Georgia, United States
🇺🇸Tulane University School of Medicine, New Orleans, Louisiana, United States
Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Tulane University School of Medicine
- Target Recruit Count
- 360
- Registration Number
- NCT04703166
- Locations
- 🇺🇸
Tulane University School of Medicine, New Orleans, Louisiana, United States
Use of Death Cafes to Prevent Burnout in ICU Healthcare Employees
- Conditions
- Burnout, ProfessionalBurnout, PsychologicalAnxietyBurnoutDepression
- First Posted Date
- 2020-04-15
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Tulane University School of Medicine
- Target Recruit Count
- 340
- Registration Number
- NCT04347811
- Locations
- 🇺🇸
Tulane Medical Center, New Orleans, Louisiana, United States
🇺🇸University Medical Center, New Orleans, Louisiana, United States
🇺🇸Children's Hospital New Orleans, New Orleans, Louisiana, United States
Intensive Care Unit (ICU) Diary Project
- Conditions
- PTSDPost ICU Syndrome
- First Posted Date
- 2020-03-12
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Tulane University School of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT04305353
- Locations
- 🇺🇸
Tulane University School of Medicine, New Orleans, Louisiana, United States
- Prev
- 1
- 2
- 3
- 4
- Next
News
Radiopharm Theranostics Appoints Leading Prostate Cancer Expert Dr. Oliver Sartor to Scientific Advisory Board
Radiopharm Theranostics has appointed Dr. Oliver Sartor, an internationally recognized medical oncologist specializing in prostate cancer and radiopharmaceutical therapies, to its Scientific Advisory Board.
Healthcare Leaders Call for Value-Based Cancer Care Reform to Address Cost and Access Barriers
Healthcare experts at PCOC meeting emphasize urgent need to align cancer care with value-based principles, addressing high treatment costs that limit access to life-saving therapies.